PLA2G3 Antikörper (Internal Region)

Produktnummer ABIN2469549

Produktdetails anti-PLA2G3 Antikörper

Target: PLA2G3 (Phospholipase A2, Group III (PLA2G3))

Bindungsspezifität: Internal Region

Reaktivität: Human, Rind (Kuh), Affe, Schwein, Gorilla, Gibbon

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLA2G3 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC)

Spezifität: BLAST analysis of the peptide immunogen showed no homology with other human proteins.

Aufreinigung: Immunoaffinity Chromatography

Immunogen: PLA2G3 antibody was raised against a peptide located near the internal domain of PLA2G3 (Human).

Anwendungsinformationen

Applikationshinweise: PLA2G3 antibody can be used in ELISA, and immunohistochemistry starting at 10 μg/mL.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS, 0.1 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: As with all antibodies avoid freeze/thaw cycles.

Lagerung: 4 °C/-80 °C

Informationen zur Lagerung: PLA2G3 antibody should be stored long term (months) at -80 °C and short term (days) at 4 °C.

Details zu PLA2G3

Target: PLA2G3 (Phospholipase A2, Group III (PLA2G3))

Andere Bezeichnung: PLA2G3 (PLA2G3 Produkte)

Synonyme: PLA2G3 antikoerper, GIII-SPLA2 antikoerper, SPLA2III antikoerper, 9130003P18Rik antikoerper, phospholipase A2 group III antikoerper, phospholipase A2, group III antikoerper, PLA2G3 antikoerper, Pla2g3 antikoerper

Hintergrund: Human group III secreted phospholipase A2 belongs to a superfamily of intracellular and secreted enzymes that catalyze the hydrolysis of glycerophospholipids at the sn-2 position to release fatty acids and lysophospholipids. Group III PLA2 enzymes were originally identified in invertebrates such as bees and scorpions. Human group III sPLA2 has been shown to be a calcium dependent enzyme. It consists of a central group III sPLA2 domain flanked by unique N- and C-terminal domains that are proteolytically removed in most tissues. The sPLA2 domain is sufficient for catalytic activity. SPLA2-III is preferentially expressed in the microvascular endothelium of tissues with inflammation, ischemic injury and cancer.

Gen-ID: 50487

UniProt: Q9NZ20